Arachnology and toxinology have increasingly illuminated the structural, biochemical and evolutionary diversity of venom ...

Introduction To quantify the impact of tropical cyclones on dengue transmission dynamics and related disease burden by ...

Since establishing MRD and Immune Medicine as separate operating segments under Adaptive in 2024, both businesses have continued to advance. MRD has achieved significant scale, expanded reimbursement, ...

A lot of things need to go right on a molecular level for immune cells to launch an adaptive response to an infection. B cells can produce different classes of antibodies tailored for specific ...

Adaptive Biotechnologies said on Monday it planned to separate its immune medicine ​business from its residual cancer-testing unit, ‌as it reviews options for the drug-discovery business and focuses ...

Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

Multilateralism is not an option but a necessity as we build back a better world with more equality and resilience, and a more sustainable world." - Secretary-General António Guterres Multilateralism, ...